Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Improved MRSI in a Murine Glioma Model Using semiLASER, Refining the Metabolomics Data Obtained from Murine Models

  • Javed, Zoona|||0009-0009-8279-9744
  • Martinez, Gary V.|||0000-0002-6204-8363
  • Mulero-Acevedo, Marta|||0000-0002-3600-8907
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Cabañas Egaña, Miquel|||0000-0003-0104-0197
  • Lope-Piedrafita, Silvia|||0000-0002-8127-6425
Background: Magnetic resonance spectroscopic imaging (MRSI) offers valuable metabolic information for assessing brain tumor progression and therapeutic response, but its performance in rodent models is often hindered by the low signal-to-noise ratio (SNR) and spatially heterogeneous spectral quality, particularly in peripheral voxels. These issues reduce the number of usable spectra available for quantitative and classifier-based analyses. To address this, we implemented a multi-voxel MRSI-semiLASER sequence-widely recommended in clinical practice-on a 7T Bruker Biospec system running ParaVision 5.1 to improve spectral homogeneity in mouse brain tumor studies. Results: Compared with the vendor CSI-PRESS sequence, MRSI-semiLASER produced more uniform spectra across the grid and achieved up to a 1.2-fold SNR increase in murine glioma, enabling a 20% reduction in slice thickness without compromising spectral quality. Importantly, the sequence produced a substantial gain in the proportion of spectra amenable to analysis, particularly in outer grid voxels that frequently fail with CSI-PRESS. The implemented MRSI-semiLASER sequence and instructions are openly available to the community. Conclusions: MRSI-semiLASER improves spectral homogeneity, increases the proportion of usable spectra, and supports higher spatial detail. These technical improvements may enhance data yield per subject and may facilitate future applications such as more robust pattern recognition workflows and greater data efficiency in longitudinal studies, although such aspects were not evaluated here.
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Numerical analysis of the effect of heterogeneity on CO2 dissolution enhanced by gravity-driven convection

  • Wang, Yufei
  • Fernández García, Daniel|||0000-0002-4667-3003
  • Saaltink, Maarten Willem|||0000-0003-0553-4573
Dissolution trapping of CO2 in brine can mitigate the risk of supercritical CO2 leakage during long-term geological carbon sequestration (GCS). The dissolution of overlying supercritical CO2 into brine increases the density of brine in its upper portion, which causes gravity-driven convection (GDC) and thus significantly increases the rate of CO2 dissolution. To date, most studies on GDC-enhanced dissolution are based on homogeneous media, and only few studies exist on the effect of heterogeneity on GDC-enhanced dissolution. Here, we study the effect of heterogeneity and anisotropy on GDC-enhanced dissolution rate using numerical simulations with randomly obtained permeability fields. Dissolution rates calculated by these simulations are related to properties of the permeability field using least-squares regression. We obtained two empirical formulas for predicting the asymptotic GDC-enhanced dissolution rate. In the first formula the dissolution rate is almost linearly proportional to the dimensionless equivalent vertical permeability. In the second one the dissolution rate is linearly proportional to a dimensionless vertical finger-tip velocity. This indicates that the GDC-enhanced dissolution can be predicted using either the equivalent vertical permeability or the vertical finger-tip velocity. Furthermore, both formulas demonstrate that higher-permeability anisotropy results in lower dissolution rates, suggesting that pronounced horizontal stratification can inhibit the dissolution of CO2., This research has been supported by the European Commission, EU Horizon 2020 Framework Programme(grant no. H2020-MSCA-ITN-2018); the Ministerio de Economía y Competitividad (grant no. RTI 2018-101990-B-100, MINECO/FEDER); and the Catalan Agency for Management of University and Research Grants, FI 2017 (grant no. EMC/2199/2017)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gülnur
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
  • Julia Sape, Margarida
Magnetic resonance spectroscopy (MRS) is an MR technique that provides informa-tion about the biochemistry of tissues in a noninvasive way. MRS has been widelyused for the study of brain tumors, both preoperatively and during follow-up. In thisstudy, we investigated the performance of a range of variants of unsupervised matrixfactorization methods of the non-negative matrix underapproximation (NMU) family,namely, sparse NMU, global NMU, and recursive NMU, and compared them withconvex non-negative matrix factorization (C-NMF), which has previously shown agood performance on brain tumor diagnostic support problems using MRS data. Thepurpose of the investigation was 2-fold: first, to ascertain the differences among thesources extracted by these methods; and second, to compare the influence of eachmethod in the diagnostic accuracy of the classification of brain tumors, using them asfeature extractors. We discovered that, first, NMU variants found meaningful sourcesin terms of biological interpretability, but representing parts of the spectrum, incontrast to C-NMF; and second, that NMU methods achieved better classificationaccuracy than C-NMF for the classification tasks when one class was notmeningioma., H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. AEI Research Project PID2019-104551RB-I00. Centro de Investigacion Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on September 12, 2022], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. XartecSalut, 2018 XARDI 00016 and 2021 XARDI 00021., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Advances in the use of deep learning for the analysis of magnetic resonance image in neuro-oncology

  • Pitarch i Abaigar, Carla|||0000-0002-6015-244X
  • Ungan, Gülnur
  • Julia Sape, Margarida
  • Vellido Alcacena, Alfredo|||0000-0002-9843-1911
Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging., This research was funded by H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120; Proyectos de investigación en salud 2020, grant number PI20/00064. PID2019-104551RB-I00; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN (http://www.ciber-bbn.es/en, accessed on 3 November 2023), CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER); Spanish Agencia Española de Investigación (AEI) PID2022-143299OB-I00 grant; XartecSalut 2021-XARDI-00021. Carla Pitarch is a fellow of Eurecat’s “Vicente López” Ph.D. grant program., Peer Reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Model-Based Evaluation of Methods for Respiratory Sinus Arrhythmia Estimation

  • Morales J.
  • Moeyersons J.
  • Armanac P.
  • Orini M.
  • Faes L.
  • Overeem S.
  • Van Gilst M.
  • Van Dijk J.
  • Van Huffel S.
  • Bailon R.
  • Varon C.
Objective: Respiratory sinus arrhythmia (RSA) refers to heart rate oscillations synchronous with respiration, and it is one of the major representations of cardiorespiratory coupling. Its strength has been suggested as a biomarker to monitor different conditions, and diseases. Some approaches have been proposed to quantify the RSA, but it is unclear which one performs best in specific scenarios. The main objective of this study is to compare seven state-of-the-art methods for RSA quantification using data generated with a model proposed to simulate, and control the RSA. These methods are also compared, and evaluated on a real-life application, for their ability to capture changes in cardiorespiratory coupling during sleep. Methods: A simulation model is used to create a dataset of heart rate variability, and respiratory signals with controlled RSA, which is used to compare the RSA estimation approaches. To compare the methods objectively in real-life applications, regression models trained on the simulated data are used to map the estimates to the same measurement scale. Results, and conclusion: RSA estimates based on cross entropy, time-frequency coherence, and subspace projections showed the best performance on simulated data. In addition, these estimates captured the expected trends in the changes in cardiorespiratory coupling during sleep similarly. Significance: An objective comparison of methods for RSA quantification is presented to guide future analyses. Also, the proposed simulation model can be used to compare existing, and newly proposed RSA estimates.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Numerical analysis of the effect of heterogeneity on CO2 dissolution enhanced by gravity-driven convection

  • Wang, Yufei
  • Fernández García, Daniel
  • Saaltink, Maarten Willem
Dissolution trapping of CO2 in brine can mitigate the risk of supercritical CO2 leakage during long-term geological carbon sequestration (GCS). The dissolution of overlying supercritical CO2 into brine increases the density of brine in its upper portion, which causes gravity-driven convection (GDC) and thus significantly increases the rate of CO2 dissolution. To date, most studies on GDC-enhanced dissolution are based on homogeneous media, and only few studies exist on the effect of heterogeneity on GDC-enhanced dissolution. Here, we study the effect of heterogeneity and anisotropy on GDC-enhanced dissolution rate using numerical simulations with randomly obtained permeability fields. Dissolution rates calculated by these simulations are related to properties of the permeability field using least-squares regression. We obtained two empirical formulas for predicting the asymptotic GDC-enhanced dissolution rate. In the first formula the dissolution rate is almost linearly proportional to the dimensionless equivalent vertical permeability. In the second one the dissolution rate is linearly proportional to a dimensionless vertical finger-tip velocity. This indicates that the GDC-enhanced dissolution can be predicted using either the equivalent vertical permeability or the vertical finger-tip velocity. Furthermore, both formulas demonstrate that higher-permeability anisotropy results in lower dissolution rates, suggesting that pronounced horizontal stratification can inhibit the dissolution of CO2., This research has been supported by the European Commission, EU Horizon 2020 Framework Programme(grant no. H2020-MSCA-ITN-2018); the Ministerio de Economía y Competitividad (grant no. RTI 2018-101990-B-100, MINECO/FEDER); and the Catalan Agency for Management of University and Research Grants, FI 2017 (grant no. EMC/2199/2017)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gülnur
  • Arus Caraltó, Carles
  • Vellido Alcacena, Alfredo
  • Julia Sape, Margarida
Magnetic resonance spectroscopy (MRS) is an MR technique that provides informa-tion about the biochemistry of tissues in a noninvasive way. MRS has been widelyused for the study of brain tumors, both preoperatively and during follow-up. In thisstudy, we investigated the performance of a range of variants of unsupervised matrixfactorization methods of the non-negative matrix underapproximation (NMU) family,namely, sparse NMU, global NMU, and recursive NMU, and compared them withconvex non-negative matrix factorization (C-NMF), which has previously shown agood performance on brain tumor diagnostic support problems using MRS data. Thepurpose of the investigation was 2-fold: first, to ascertain the differences among thesources extracted by these methods; and second, to compare the influence of eachmethod in the diagnostic accuracy of the classification of brain tumors, using them asfeature extractors. We discovered that, first, NMU variants found meaningful sourcesin terms of biological interpretability, but representing parts of the spectrum, incontrast to C-NMF; and second, that NMU methods achieved better classificationaccuracy than C-NMF for the classification tasks when one class was notmeningioma., H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120. Proyectos de investigación en salud 2020, grant numbers PI20/00064 and PI20/00360. Spanish Ministerio de Economía y Competitividad SAF2014-52332-R. AEI Research Project PID2019-104551RB-I00. Centro de Investigacion Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on September 12, 2022], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER). Spanish AEI PID2019-104551RB-I00 grant. XartecSalut, 2018 XARDI 00016 and 2021 XARDI 00021., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Advances in the use of deep learning for the analysis of magnetic resonance image in neuro-oncology

  • Pitarch i Abaigar, Carla
  • Ungan, Gülnur
  • Julia Sape, Margarida
  • Vellido Alcacena, Alfredo
Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging., This research was funded by H2020-EU.1.3.—EXCELLENT SCIENCE—Marie Skłodowska-Curie Actions, grant number H2020-MSCA-ITN-2018-813120; Proyectos de investigación en salud 2020, grant number PI20/00064. PID2019-104551RB-I00; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN (http://www.ciber-bbn.es/en, accessed on 3 November 2023), CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU Fondo Europeo de Desarrollo Regional (FEDER); Spanish Agencia Española de Investigación (AEI) PID2022-143299OB-I00 grant; XartecSalut 2021-XARDI-00021. Carla Pitarch is a fellow of Eurecat’s “Vicente López” Ph.D. grant program., Peer Reviewed, Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune system-related changes in preclinical GL261 glioblastoma under TMZ treatment, Explaining MRSI-based nosological imaging findings with RT-PCR analyses

  • Calero-Perez, Pilar|||0000-0001-9370-3757
  • Wu, Shuang|||0000-0001-7618-5476
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
Glioblastomas (GB) are brain tumours with poor prognosis even after aggressive therapy. Previous work suggests that magnetic resonance spectroscopic imaging (MRSI) could act as a biomarker of efficient immune system attack onto GB, presenting oscillatory changes. Glioma-associated microglia/macrophages (GAMs) constitute the most abundant non-tumour cell type within the GB and can be polarised into anti-tumour (M1) or pro-tumour (M2) phenotypes. One of the mechanisms to mediate immunosuppression in brain tumours is the interaction between programmed cell death-1 ligand 1 (PD-L1) and programmed cell death-1 receptor (PD-1). We evaluated the subpopulations of GAMs in responding and control GB tumours to correlate PD-L1 expression to GAM polarisation in order to explain/validate MRSI-detected findings. Mice were evaluated by MRI/MRSI to assess the extent of response to treatment and with qPCR for GAMs M1 and M2 polarisation analyses. M1/M2 ratios and PD-L1 expression were higher in treated compared to control tumours. Furthermore, PD-L1 expression was positively correlated with the M1/M2 ratio. The oscillatory change in the GAMs prevailing population could be one of the key causes for the differential MRSI-detected pattern, allowing this to act as immune system activity biomarker in future work.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response, challenges, Obstacles and Future Perspectives

  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
This hypothesis proposal addresses three major questions: (1) Why do we need imaging biomarkers for assessing the efficacy of immune system participation in glioblastoma therapy response? (2) Why are they not available yet? and (3) How can we produce them? We summarize the literature data supporting the claim that the immune system is behind the efficacy of most successful glioblastoma therapies but, unfortunately, there are no current short-term imaging biomarkers of its activity. We also discuss how using an immunocompetent murine model of glioblastoma, allowing the cure of mice and the generation of immune memory, provides a suitable framework for glioblastoma therapy response biomarker studies. Both magnetic resonance imaging and magnetic resonance-based metabolomic data (i.e., magnetic resonance spectroscopic imaging) can provide non-invasive assessments of such a system. A predictor based in nosological images, generated from magnetic resonance spectroscopic imaging analyses and their oscillatory patterns, should be translational to clinics. We also review hurdles that may explain why such an oscillatory biomarker was not reported in previous imaging glioblastoma work. Single shot explorations that neglect short-term oscillatory behavior derived from immune system attack on tumors may mislead actual response extent detection. Finally, we consider improvements required to properly predict immune system-mediated early response (1-2 weeks) to therapy. The sensible use of improved biomarkers may enable translatable evidence-based therapeutic protocols, with the possibility of extending preclinical results to human patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Using Single-Voxel Magnetic Resonance Spectroscopy Data Acquired at 1.5T to Classify Multivoxel Data at 3T, A Proof-of-Concept Study

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Pons-Escoda, Albert|||0000-0003-4167-8291
  • Ulinic, Daniel|||0009-0006-3318-0839
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
In vivo magnetic resonance spectroscopy (MRS) has two modalities, single-voxel (SV) and multivoxel (MV), in which one or more contiguous grids of SVs are acquired. Purpose: To test whether MV grids can be classified with models trained with SV. Methods: Retrospective study. Training dataset: Multicenter multiformat SV INTERPRET, 1.5T. Testing dataset: MV eTumour, 3T. Two classification tasks were completed: 3-class (meningioma vs. aggressive vs. normal) and 4-class (meningioma vs. low-grade glioma vs. aggressive vs. normal). Five different methods were tested for feature selection. The classification was implemented using linear discriminant analysis (LDA), random forest, and support vector machines. The evaluation was completed with balanced error rate (BER) and area under the curve (AUC) on both sets. The accuracy in class prediction was calculated by developing a solid tumor index (STI) and segmentation accuracy with the Dice score. Results: The best method was sequential forward feature selection combined with LDA, with AUCs = 0.95 (meningioma), 0.89 (aggressive), 0.82 (low-grade glioma), and 0.82 (normal). STI was 66% (4-class task) and 71% (3-class task) because two cases failed completely and two more had suboptimal STI as defined by us. Discussion: The reasons for failure in the classification of the MV test set were related to the presence of artifacts.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
Magnetic resonance spectroscopy (MRS) is an MR technique that provides information about the biochemistry of tissues in a noninvasive way. MRS has been widely used for the study of brain tumors, both preoperatively and during follow-up. In this study, we investigated the performance of a range of variants of unsupervised matrix factorization methods of the non-negative matrix underapproximation (NMU) family, namely, sparse NMU, global NMU, and recursive NMU, and compared them with convex non-negative matrix factorization (C-NMF), which has previously shown a good performance on brain tumor diagnostic support problems using MRS data. The purpose of the investigation was 2-fold: first, to ascertain the differences among the sources extracted by these methods; and second, to compare the influence of each method in the diagnostic accuracy of the classification of brain tumors, using them as feature extractors. We discovered that, first, NMU variants found meaningful sources in terms of biological interpretability, but representing parts of the spectrum, in contrast to C-NMF; and second, that NMU methods achieved better classification accuracy than C-NMF for the classification tasks when one class was not meningioma.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Advances in the Use of Deep Learning for the Analysis of Magnetic Resonance Image in Neuro-Oncology

  • Pitarch, Carla|||0000-0002-6015-244X
  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
  • Vellido, Alfredo|||0000-0002-9843-1911
Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous

  • Ungan, Gulnur Semahat|||0000-0002-5436-4665
  • Pons-Escoda, Albert|||0000-0003-4167-8291
  • Ulinic, Daniel|||0009-0006-3318-0839
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Ortega-Martorell, Sandra|||0000-0001-9927-3209
  • Olier, Iván|||0000-0002-5679-7501
  • Vellido, Alfredo|||0000-0002-9843-1911
  • Majos, Carles|||0000-0003-0468-5150
  • Julià Sapé, Ma. Margarita|||0000-0002-3316-9027
The standard treatment in glioblastoma includes maximal safe resection followed by concomitant radiotherapy plus chemotherapy and adjuvant temozolomide. The first follow-up study to evaluate treatment response is performed 1 month after concomitant treatment, when contrast-enhancing regions may appear that can correspond to true progression or pseudoprogression. We retrospectively evaluated 31 consecutive patients at the first follow-up after concomitant treatment to check whether the metabolic pattern assessed with multivoxel MRS was predictive of treatment response 2 months later. We extracted the underlying metabolic patterns of the contrast-enhancing regions with a blind-source separation method and mapped them over the reference images. Pattern heterogeneity was calculated using entropy, and association between patterns and outcomes was measured with Cramér's V. We identified three distinct metabolic patterns-proliferative, necrotic, and responsive, which were associated with status 2 months later. Individually, 70% of the patients showed metabolically heterogeneous patterns in the contrast-enhancing regions. Metabolic heterogeneity was not related to the regions' size and only stable patients were less heterogeneous than the rest. Contrast-enhancing regions are also metabolically heterogeneous 1 month after concomitant treatment. This could explain the reported difficulty in finding robust pseudoprogression biomarkers.